Logo image of DSM

BNYM STRAT MUNI BND (DSM) Stock Overview

NYSE:DSM - US09662E1091

5.68 USD
+0.03 (+0.53%)
Last: 8/29/2025, 8:17:27 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DSM. DSM was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of DSM have multiple concerns. DSM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DSM had negative earnings in the past year.
In the past year DSM has reported a negative cash flow from operations.
DSM had positive earnings in 4 of the past 5 years.
DSM had a positive operating cash flow in 4 of the past 5 years.
DSM Yearly Net Income VS EBIT VS OCF VS FCFDSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

Industry RankSector Rank
ROA -1.64%
ROE -2.62%
ROIC 2.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSM Yearly ROA, ROE, ROICDSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 5 -5 -10 -15

1.3 Margins

DSM's Profit Margin has been stable in the last couple of years.
In the last couple of years the Operating Margin of DSM has declined.
DSM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 58.23%
PM (TTM) N/A
GM 61.59%
OM growth 3Y-11.27%
OM growth 5Y-5.57%
PM growth 3Y9.83%
PM growth 5Y-0.03%
GM growth 3Y-10.36%
GM growth 5Y-4.79%
DSM Yearly Profit, Operating, Gross MarginsDSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 100 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DSM has been reduced compared to 5 years ago.
DSM Yearly Shares OutstandingDSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 10M 20M 30M 40M
DSM Yearly Total Debt VS Total AssetsDSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 200M 400M 600M

2.2 Solvency

DSM has an Altman-Z score of 0.88. This is a bad value and indicates that DSM is not financially healthy and even has some risk of bankruptcy.
DSM has a Debt/Equity ratio of 0.58. This is a neutral value indicating DSM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACCN/A
WACCN/A
DSM Yearly LT Debt VS Equity VS FCFDSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.53 indicates that DSM should not have too much problems paying its short term obligations.
A Quick Ratio of 1.53 indicates that DSM should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
DSM Yearly Current Assets VS Current LiabilitesDSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

DSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.91%.
Measured over the past years, DSM shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.01% on average per year.
DSM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.76%.
Measured over the past years, DSM shows a decrease in Revenue. The Revenue has been decreasing by -4.34% on average per year.
EPS 1Y (TTM)-173.91%
EPS 3Y9.33%
EPS 5Y-4.01%
EPS Q2Q%-431.58%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y-1.1%
Revenue growth 5Y-4.34%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DSM Yearly Revenue VS EstimatesDSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSM Price Earnings VS Forward Price EarningsDSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSM Per share dataDSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.07%, DSM is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.35, DSM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.07%

5.2 History

DSM has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSM Yearly Dividends per shareDSM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of DSM are negative and hence is the payout ratio. DSM will probably not be able to sustain this dividend level.
DP-126.37%
EPS Next 2YN/A
EPS Next 3YN/A
DSM Yearly Income VS Free CF VS DividendDSM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 20M -20M 40M -40M 60M -60M

More info and screens

BNYM STRAT MUNI BND

NYSE:DSM (8/29/2025, 8:17:27 PM)

5.68

+0.03 (+0.53%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)02-02 2026-02-02
Inst Owners49.45%
Inst Owner Change3.55%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap280.76M
Analysts0
Price TargetN/A
Short Float %0.12%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 4.07%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-126.37%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-13 2025-08-13 (0.023)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.76
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.45
BVpS6.17
TBVpS6.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.64%
ROE -2.62%
ROCE 2.66%
ROIC 2.1%
ROICexc 2.1%
ROICexgc 2.1%
OM 58.23%
PM (TTM) N/A
GM 61.59%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-7.61%
ROICexcg growth 5Y-5.68%
ROICexc growth 3Y-7.61%
ROICexc growth 5Y-5.68%
OM growth 3Y-11.27%
OM growth 5Y-5.57%
PM growth 3Y9.83%
PM growth 5Y-0.03%
GM growth 3Y-10.36%
GM growth 5Y-4.79%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage -2.94
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 0.88
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.91%
EPS 3Y9.33%
EPS 5Y-4.01%
EPS Q2Q%-431.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.76%
Revenue growth 3Y-1.1%
Revenue growth 5Y-4.34%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.65%
EBIT growth 3Y-12.24%
EBIT growth 5Y-9.68%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-127.04%
OCF growth 3YN/A
OCF growth 5YN/A